Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Northwest Biotherapeutics Inc

+ Add to Watchlist


8.4700 USD 0.1500 1.74%

As of 20:10:00 ET on 04/24/2015.

Company Profile for Northwest Biotherapeutics Inc (NWBO)

Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.

Contact Information

Northwest Biotherapeutics Inc

4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
United States
Phone: 1-240-497-9024

Key Executives for Northwest Biotherapeutics Inc (NWBO)

Linda F PowersChairman/President/CEOMarnix L BoschChief Technology Officer
Alton L BoyntonChief Scientific OfficerAnthony E Maida IIISenior VP:Clinical Research
Leslie J GoldmanSenior VP:Business Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil